Evaluation of the Effect of Food and Posture on the Pharmacokinetics of Paliperidone After a Single Administration of 12 mg ER OROS Paliperidone to Healthy Men.
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2010
At a glance
- Drugs Paliperidone (Primary)
- Indications Aggression; Bipolar disorders; Insomnia; Manic episodes; Schizoaffective disorder; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 10 Jun 2017 Biomarkers information updated
- 23 Mar 2010 Actual patient number (74) added as reported by ClinicalTrials.gov.
- 12 Dec 2009 New trial record